Advertisement
Screener

RENOVORX, INC. (RNXT) Revenue Breakdown

RENOVORX, INC. Revenue Breakdown

No Revenue Breakdown for RNXT on this site yet.

  • 2025-12-31: Others Not split by product in the filing$1.12M100.00%; Total revenue $1.12M.
  • 2024-12-31: Total revenue $43.00K.

Source checked: the stored Revenue Breakdown page for RNXT.

Revenue by product

Each year (12 month)

Fiscal year endOthersTotal revenue
2025-12-31
Not split by product in the filing
$1.12M
100.00%
$1.12M
2024-12-31$43.00K

Each quarter (3 month)

Quarter endOthersTotal revenue
2026-06-30
Not split by product
$909.00K
100.00%
$909.00K
2026-03-31
Not split by product
$563.00K
100.00%
$563.00K
2025-12-31
Not split by product
$238.00K
100.00%
$238.00K
2025-09-30
Not split by product
$266.00K
100.00%
$266.00K
2025-06-30
Not split by product
$422.00K
100.00%
$422.00K
2025-03-31
Not split by product
$197.00K
100.00%
$197.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
Pulmonx Corp (LUNG)United States$0.082B-1.16
CVRx, Inc. (CVRX)United States$0.067B-2.62
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
DarioHealth Corp. (DRIO)$0.066B-1.39
LENSAR, Inc. (LNSR)United States$0.087B2.02
Microbot Medical Inc. (MBOT)$0.089B-7.97
TELA Bio, Inc. (TELA)United States$0.057B-0.82
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Spectral AI, Inc. (MDAI)United States$0.052B